Summary of the Conference Call for Haijia Medical Company Overview - **Company**: Haijia Medical - **Industry**: Healthcare Services Key Points Financial Performance - In 2025, operating cash flow is expected to grow by 34.4% year-on-year to RMB 9.5 billion, driven by increased revenue from self-paid services and improved collection efficiency with accounts receivable down by 16.6% [2][3] - Inventory turnover efficiency improved by over 10% [2] - Depreciation and amortization is approximately RMB 310 million, indicating a strong cash return phase [2] - The company has a maximum capacity of 14,000 beds, sufficient to support five years of development with no new hospital construction plans in the short term [2][3] Capital Allocation and Shareholder Returns - The company plans to execute a RMB 300 million share buyback and intends to cancel the repurchased shares [2][9] - There is a focus on reducing interest-bearing debt and exploring quality domestic and international acquisitions [2][3] - Expected normalized free cash flow post the opening of Changshu Hospital in late 2026 is projected to reach RMB 800-900 million [2] Growth Areas - International medical and innovative business segments are emerging growth drivers, with Chongqing Hospital's international department generating over RMB 8 million in revenue in December 2025 [2][4] - The brain-computer interface business is expected to generate annual revenue of approximately RMB 250-260 million, with a dedicated division established in 2026 [2][11] M&A and Goodwill Impairment - The goodwill impairment related to Suzhou Yongding Hospital was due to high initial market valuations and changes in the macro environment, but the hospital's operations are currently stable [7] - Other acquired hospitals show no impairment pressure, indicating strong operational management capabilities [7] Response to Industry Changes - The company emphasizes a "patient-first" culture and has seen patient visits reach 4.6 million in 2025, with a five-year compound growth rate of 35% [5][6] - Continuous investment in talent and technology, with 108 national-level professionals and 907 senior professionals by 2025 [6] - The company is focusing on refined management practices to enhance operational efficiency [6] Market Outlook and Strategy - The company is optimistic about the long-term healthcare demand driven by aging demographics, despite short-term policy uncertainties [5][14] - Plans to leverage the long-term care insurance policy to tap into the growing demand for integrated medical and nursing services [8][16] AI Integration - AI is being integrated into management and service efficiency, with applications in supply chain and administrative management [13] - The company has developed an AI customer service system to enhance patient interaction and satisfaction [13] Future Projections - The company expects to achieve breakeven cash flow for the Texas Hospital by the end of 2026, with Wuxi Hospital anticipated to connect to medical insurance by March-April 2026 [9] - Long-term growth is expected for Chang'an Hospital, with multiple growth points identified in critical care and oncology [17] Valuation Perspective - The company's value is considered significantly undervalued, with approximately RMB 800 million in free cash flow and a focus on long-term cash flow stability [18] Additional Insights - The company maintains a cautious approach to overseas acquisitions, focusing on smaller projects initially while prioritizing domestic growth opportunities [16] - The operational efficiency and strategic management are seen as key competitive advantages in a changing healthcare landscape [16]

Group 1 - The core viewpoint of the articles highlights the efforts of Qinghai Province's Medical Insurance Bureau to enhance the accessibility and affordability of healthcare for insured individuals during the 14th Five-Year Plan period [1][2] Group 2 - Qinghai has dynamically adjusted its medical insurance drug list, incorporating 387 national negotiated drugs and competitive drugs into a "dual-channel" guarantee system to improve patient access to medications [1] - An additional 150 types of Tibetan medicinal herbs have been included in the medical insurance payment scope, making a total of 531 types and 3200 items available [1] - The province has included 499 ethnic medical diagnosis and treatment projects in the medical insurance payment scope, achieving an inclusion rate of 88% [1] - 127 surgical procedures have been added to the day surgery settlement range without a threshold, reimbursed according to inpatient policies [1] - Six specific Tibetan and Chinese medicine advantageous disease categories have been included in the day ward medical insurance settlement, with no bed fees charged for hospitalization and nursing fees set at 50% of the standard for tertiary care [1] Group 3 - The province has integrated village health clinics into the medical insurance designated point system, with 4343 out of 4469 clinics now covered, ensuring basic coverage for all administrative villages [2] - A smart regulatory system for medical insurance has been established to enhance early detection and management of illegal activities [2] - The province has optimized the cross-regional medical treatment registration service, allowing for online registration through WeChat mini-programs and the Qinghai Medical Insurance App, effectively eliminating the need for in-person registration [2] - The direct settlement channel has been established to resolve issues related to insured individuals having to pay upfront for services [2]